Welcome to our Q3 2023 Quarterly Report, carefully curated with topics that we believe will be of interest to our clients and partners. We also share M&A market commentaries and the latest Bryan, Garnier & Co deals in the healthcare, software & fintech, industrial tech, energy transition & sustainability, and business & tech-enabled services sectors. This report, we deep dive on:
- Uncovering the truth behind alternative protein
In a world of information overload, we cut through the clutter to explore the production, feasibility, and implications of the alternative protein industry. Discover how fermentation is transforming the landscape and dispelling common industry myths. - Space: The Final Frontier
With a remarkable 45% YoY increase in space deals leading up to Q3 2023, we delve into the challenges, M&A activity, and market potential of the NewSpace movement. The stars have aligned for exciting opportunities. - M&A deals activity
Gain a deeper understanding of the M&A market in our sectors of expertise and the profound impact of the current macro environment, as our partners provide their invaluable perspectives.
These insights are designed to empower investors looking to navigate the ever-evolving market trends.
Download the report and stay ahead of the curve. Have questions or want to explore opportunities further? Contact us at communication@bryangarnier.com and let us advise you through your growth journey or help you spot the best investment opportunities.
About Bryan, Garnier & Co
Bryan, Garnier & Co is a European growth investment bank that helps healthcare and technology companies become global champions. By combining extensive sector expertise with an entrepreneurial mindset, Bryan Garnier provides companies and their investors with independent growth strategic advice, and privileged access to buyers and capital in Europe, the US and Asia.
As a full-service investment bank, the firm offering includes private and public growth financing solutions, mergers and acquisitions (M&A) advisory, research insights, and institutional sales & execution. Founded in 1996, Bryan Garnier & Co is an independent partnership with around 200 employees located in major financial centres in Europe and the US.